Multiple Myeloma Research Foundation
Last Modified: August 9, 2007
Conference Dates: November 3, 2007
Conference Location: Stanford University campus
Sponsoring Group: Multiple Myeloma Research Foundation
Conference Web Page URL: www.multiplemyeloma.org/symposia
Topics Covered: Clinical Controversies in Multiple Myeloma provides the latest insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease, and supportive care.
Conference Objectives: Upon completion of program, participants should be able to Identify the prognostic indicators and diagnostic approaches to multiple myeloma; Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management; Describe the role and appropriate use of novel treatments for multiple myeloma throught the disease progression.
Who Should Attend: Hematologists, Medical Oncologists, Oncology Nurses, Internists with recently diagnosed patients
Conference Agenda: Registration and continental breakfast; Frontline Therapu; Transplant; Relapsed/Refractory Disease; Supportive Care; Clinical Trials, Panel Q&A
Registration Information: To register online visit www.multiplemyeloma.org/symposia or contact Sara Tyghter at 203.652.0219
Conference Fees: Free
Continuing Education: Yes
Miscellany: Curatio CME Institute designates this educational activity for a maximum 2.75 AMA PRA Category 1 Credit(s).
Mar 9, 2010 - The presence and number of focal lesions detected by whole-body magnetic resonance imaging strongly predicts the conversion of asymptomatic multiple myeloma to symptomatic disease, according to a study published online Feb. 22 in the Journal of Clinical Oncology. In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age.
May 3, 2012